Unicycive Therapeutics
UNCY
UNCY
30 hedge funds and large institutions have $27.4M invested in Unicycive Therapeutics in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
5.1% less ownership
Funds ownership: 40.69% → 35.59% (-5.1%)
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.85M | |
| 2 | +$512K | |
| 3 | +$292K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$231K |
| 5 |
Goldman Sachs
New York
|
+$197K |
Top Sellers
| 1 | -$104K | |
| 2 | -$56.2K | |
| 3 | -$55K | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$12.7K |
